We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Moon shot

5 Jan 2022 By Robert Cyran

Its Covid-19 vaccine is one of the world’s biggest medical products, yet that doesn’t justify even half of Moderna’s $94 bln market value. Like Elon Musk’s $1.2 trln carmaker, the company is now a bet on dominating markets yet to exist. That suggests a volatile future for investors.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)